Searched for
GRANULES INDIA RESULTS
For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsAs the stock market witnesses a recovery, what one should watch for is market breadth. Also, check which sectors are leading the rally. Why...
For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
In war, anything can happen; in investing, only management matters. 6 stocks from different sectors with upside potential of up to 27%Net margin is a useful metric. It tells you how much profit remains after costs, interest, and tax are deducted from revenue. But it does n...
These large-, mid- and small-cap stocks can give more than 22% return in 1 year, according to analystsWhen a market is in a secular correction due to fears that the economy might take a hit for some reason, the fall is generally across the b...
Correction may be opportunity for some: 5 mid-cap stocks from different sectors with an upside potential up to 28%Will they? Won’t they? Even as uncertainty persists over the proposed second round talks between the US and Iran, markets across the globe ...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
Stocks in news: RIL, TCS, IDFC First Bank, BPCL, SpiceJetIndian equity markets saw profit booking on April 9, ending a five-day rally. Several companies like RIL, TCS, and IDFC First Bank are in f...
Granules India Q3 Results: Paracetamol maker posts marginal rise in profitDrug maker Granules India reported a marginal rise in third-quarter profit on Tuesday, helped by easing raw material costs.
Granules India Q2 Results: Profit jumps 80% boosted by Paracetamol salesThe company said 51% of its revenue came from finished dosages, which is its biggest business. Active pharmaceuticals ingredients and pharm...
Buy Granules India, target price Rs 440: Motilal OswalGranules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 9204.83 Crore) operating in Pharmaceuti...
Granules India Q1 results: Net profit up 8% to Rs 120 croreConsolidated revenue from operations of the company stood at Rs 850 crore for the quarter under consideration. It was Rs 736 crore for the ...
2 midcaps and a smallcap that may fly higher in a few weeks"At least for the next six to seven months, midcaps will be in focus and will be giving tremendous returns."
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US marketAs per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydro...
Granules India Q1 results: Net profit rises 34% to Rs 111.4 croreIts consolidated revenue from operations stood at Rs 735.59 crore for the quarter under consideration.
Buy Granules India, target Rs 141: Emkay Global Financial ServicesBuy Granules India at a price target of Rs 141.
Strong fundamentals, reasonable valuations make analysts bullish on Granules IndiaMore analysts are getting attracted to this counter because the recent correction has brought down its valuations to reasonably levels.
- Granules India Q2 net soars 228% to Rs 8 crore
Granules India Ltd today said it has registered a 228 per cent jump in net profit at Rs 8 crore for the quarter ended September 30.
'Outsource volume products to us'Granules India managing director C Krishna Prasad talks about the company's future growth plans.
- Corporate events this week
Corporate events this week